Skip to content

Pneumoconiosis and Dust Exposure China Cohort

Pneumoconiosis and Dust Exposure China Cohort

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07077382
Acronym
PANDECT
Enrollment
2000
Registered
2025-07-22
Start date
2021-05-28
Completion date
2030-05-31
Last updated
2025-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumoconiosis

Brief summary

The primary objective of this study is to characterize the demographic and clinical features of patients with occupational pneumoconiosis (hereinafter referred to as pneumoconiosis) in China. Secondary objectives include: 1) to describe the natural course of pneumoconiosis; 2) to evaluate the prognosis of pneumoconiosis patients; and 3) to assess complications and comorbidities in pneumoconiosis patients.

Interventions

None listed

Sponsors

KaiLuan General Hospital
CollaboratorOTHER
The First Affiliated Hospital of Shanxi Medical University
CollaboratorOTHER
Weifang Respiratory Disease Hospital
CollaboratorUNKNOWN
Hubei Hospital of Traditional Chinese Medicine
CollaboratorOTHER
Hunan Prevention and Treatment Institute for Occupational Diseases, China
CollaboratorUNKNOWN
The first affiliated hospital of chongqing medical and pharmaceutical college
CollaboratorUNKNOWN
Centers for Disease Control and Prevention, China
CollaboratorOTHER_GOV
Shandong Gold Mining Company Occupational Disease Precention Hospital
CollaboratorUNKNOWN
Shandong Province Hospital of occupational diseases
CollaboratorUNKNOWN
The Second Hospital of Heilongjiang Province
CollaboratorUNKNOWN
China-Japan Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed as pneumoconiosis

Exclusion criteria

* Incomplete occupational history information * Has participated in any interventional clinical research

Design outcomes

Primary

MeasureTime frameDescription
Pulmonary function test3 yearsPulmonary function tests (PFTs) are utilized to assess the severity of the patient's condition, monitor disease progression, guide therapeutic decision-making, and evaluate prognosis.

Secondary

MeasureTime frameDescription
Number of patients6 yearsThe researchers used inclusion/exclusion criteria for screening, and collected the demographic information, clinical symptoms and signs, laboratory tests, treatment, survival and other conditions of the patients who agreed to participate in the program and signed the informed consent, and collected biological specimens.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026